CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 278228-278321 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"Future clinical studies of anti-TNF therapy in CVID with granulomatous disease are warranted.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T22484","span":{"begin":0,"end":93},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T22484","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T499","span":{"begin":0,"end":93},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T499","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T25","span":{"begin":0,"end":93},"obj":"Sentence"}],"attributes":[{"subj":"T25","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2660","span":{"begin":47,"end":51},"obj":"Disease"}],"attributes":[{"id":"A2660","pred":"mondo_id","subj":"T2660","obj":"http://purl.obolibrary.org/obo/MONDO_0015517"},{"subj":"T2660","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#9a93ec","default":true},{"id":"Epistemic_Statements","color":"#a5ec93"},{"id":"CORD-19_Custom_license_subset","color":"#ec93bf"},{"id":"CORD-19-PD-MONDO","color":"#93d9ec"}]}]}}